Repository logo
 

simGWAS: a fast method for simulation of large scale case-control GWAS summary statistics

Published version
Peer-reviewed

Type

Article

Change log

Abstract

Methods for analysis of GWAS summary statistics have encouraged data sharing and democratised the analysis of different diseases. Ideal validation for such methods is application to simulated data, where some "truth" is known. As GWAS increase in size, so does the computational complexity of such evaluations; standard practice repeatedly simulates and analyses genotype data for all individuals in an example study. We have developed a novel method based on an alternative approach, directly simulating GWAS summary data, without individual data as an intermediate step. We mathematically derive the expected statistics for any set of causal variants and their effect sizes, conditional upon control haplotype frequencies (available from public reference datasets). Simulation of GWAS summary output can be conducted independently of sample size by simulating random variates about these expected values. Across a range of scenarios, our method, available as an open source R package, produces very similar output to that from simulating individual genotypes with a substantial gain in speed even for modest sample sizes. Fast simulation of GWAS summary statistics will enable more complete and rapid evaluation of summary statistic methods as well as opening new potential avenues of research in fine mapping and gene set enrichment analysis.

Description

Keywords

31 Biological Sciences, 3105 Genetics, 4202 Epidemiology, 42 Health Sciences, 4905 Statistics, 49 Mathematical Sciences, Bioengineering, Genetics, Human Genome

Journal Title

Bioinformatics

Conference Name

Journal ISSN

1367-4811
1460-2059

Volume Title

Publisher

Oxford University Press
Sponsorship
Wellcome Trust (107881/Z/15/Z)
Medical Research Council (MC_UU_00002/4)
Wellcome Trust (099772/Z/12/Z)
MF and CW are funded by the Wellcome Trust (WT099772, WT107881) and CW by the MRC (MC_UU_00002/4). MF is currently funded by Dementia Platforms UK.